Skip to content

Author

Fu-Ren Zhang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.

BACKGROUND Generalized pustular psoriasis (GPP) is a rare, severe inflammatory skin disease characterized by acute flares. Recibokibart is a humanized IgG1 monoclonal antibody targeting the interleukin-36 (IL-36) receptor. In a phase 1b open-label study, a single intravenous dose of recibokibart was associated with an...

Bao-Qi Yang, Yu-Zhen Li, Yu Wang et al. · 0 citations
Open access Aug 2026

Shared and Distinct T‑Cell Receptor Characteristics of CD4+ and CD8+ Drug-Specific T‑Cells In Vitro Generated from Healthy Donors and Hypersensitive Patients

The initiation of T-cell-mediated drug hypersensitivity reaction requires the formation of a human leukocyte antigen (HLA)-peptide-drug-T-cell receptor (TCR) complex. While specific interactions between HLA molecules and drug antigens are well-defined, the characteristics of drug binding to the TCR are unclear. Herein,...

Kanoot Jaruthamsophon, Paul J. Thomson, J. Pratoomwun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.